These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22703374)

  • 1. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program.
    Wallasch TM; Angeli A; Kropp P
    Headache; 2012; 52(7):1094-105. PubMed ID: 22703374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
    Wang SJ; Fuh JL; Lu SR; Juang KD
    Neurology; 2007 Feb; 68(8):591-6. PubMed ID: 17182975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of biofeedback in the treatment of migraine and tension type headaches.
    Mullally WJ; Hall K; Goldstein R
    Pain Physician; 2009; 12(6):1005-11. PubMed ID: 19935987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive/tertiary care for headache: a 6-month outcome study.
    Saper JR; Lake AE; Madden SF; Kreeger C
    Headache; 1999 Apr; 39(4):249-63. PubMed ID: 15613222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of a group-based acceptance and commitment additive therapy on rehabilitation of female outpatients with chronic headache: preliminary findings reducing 3 dimensions of headache impact.
    Mo'tamedi H; Rezaiemaram P; Tavallaie A
    Headache; 2012; 52(7):1106-19. PubMed ID: 22712503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study.
    Zebenholzer K; Thamer M; Wöber C
    Clin J Pain; 2012 May; 28(4):284-90. PubMed ID: 22001669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and anxiety: effect on the migraine-obesity relationship.
    Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
    Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache and anxiety-depressive disorder comorbidity: the HADAS study.
    Beghi E; Allais G; Cortelli P; D'Amico D; De Simone R; d'Onofrio F; Genco S; Manzoni GC; Moschiano F; Tonini MC; Torelli P; Quartaroli M; Roncolato M; Salvi S; Bussone G
    Neurol Sci; 2007 May; 28 Suppl 2():S217-9. PubMed ID: 17508174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated care for migraine and chronic tension-type headaches: A prospective observational study.
    Cramer H; Hehlke M; Vasmer J; Rampp T; Anheyer D; Saha FJ; Paul A; Lauche R; Dobos G
    Complement Ther Clin Pract; 2019 Aug; 36():1-6. PubMed ID: 31383425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-resistant medication overuse headache can be cured.
    Munksgaard SB; Bendtsen L; Jensen RH
    Headache; 2012; 52(7):1120-9. PubMed ID: 22724425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxation treatment of adolescent headache sufferers: results from a school-based replication series.
    Larsson B; Carlsson J; Fichtel A; Melin L
    Headache; 2005 Jun; 45(6):692-704. PubMed ID: 15953302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive inpatient treatment of refractory chronic daily headache.
    Lake AE; Saper JR; Hamel RL
    Headache; 2009 Apr; 49(4):555-62. PubMed ID: 19245391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of migraine and tension-type headache: a population-based follow-up study.
    Lyngberg AC; Rasmussen BK; Jørgensen T; Jensen R
    Neurology; 2005 Aug; 65(4):580-5. PubMed ID: 16116119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache characteristics and chronification of migraine and tension-type headache: A population-based study.
    Ashina S; Lyngberg A; Jensen R
    Cephalalgia; 2010 Aug; 30(8):943-52. PubMed ID: 20656705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.